Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Colgate-Palmolive Co Stock Research

CL

73.74USD+0.52(+0.71%)Market Closed
Watchlist

Market Summary

USD73.74+0.52
Market Closed
0.71%

CL Alerts

  • 3 major insider sales recently.

CL Stock Price

CL RSI Chart

CL Valuation

Market Cap

63.2B

Price/Earnings (Trailing)

35.42

Price/Sales (Trailing)

3.52

EV/EBITDA

18.49

Price/Free Cashflow

24.74

CL Price/Sales (Trailing)

CL Profitability

Operating Margin

56.65%

EBT Margin

13.23%

Return on Equity

-26.6K%

Return on Assets

9.88%

Free Cashflow Yield

4.04%

CL Fundamentals

CL Revenue

Revenue (TTM)

18.7B

Revenue Y/Y

7.54%

Revenue Q/Q

1.09%

CL Earnings

Earnings (TTM)

1.5B

Earnings Y/Y

-16.75%

Earnings Q/Q

34.95%

Price Action

52 Week Range

67.4082.09
(Low)(High)

Last 7 days

1.0%

Last 30 days

-1.8%

Last 90 days

-5.7%

Trailing 12 Months

-3.0%

CL Financial Health

Current Ratio

1.23

CL Investor Care

Dividend Yield

2.59%

Dividend/Share (TTM)

1.9

Diluted EPS (TTM)

1.8

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-13
Tsourapas Panagiotis
acquired
-
-
5,301
grp pres, eur& developing mkts
2023-09-13
Daniels Jennifer
acquired
-
-
5,301
clo and secretary
2023-09-13
Kooyman John W
acquired
-
-
1,950
chief of staff
2023-09-13
Malcolm Gregory
acquired
-
-
1,291
vice president and controller
2023-09-13
SUTULA STANLEY J III
acquired
-
-
7,964
chief financial officer
2023-09-13
Wallace Noel R.
acquired
-
-
28,148
chairman, president & ceo
2023-09-13
Massey Sally
acquired
-
-
3,461
chief human resources officer
2023-09-13
Parameswaran Prabha
acquired
-
-
5,301
grp pres, growth & strategy
2023-09-11
Wallace Noel R.
acquired
3,549,770
73.00
48,627
chairman, president & ceo
2023-09-11
Daniels Jennifer
sold
-1,811,020
73.3086
-24,704
clo and secretary

1–10 of 50

Which funds bought or sold CL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-13
CGC Financial Services, LLC
new
-
15,408
15,408
0.01%
2023-09-12
Farther Finance Advisors, LLC
added
2.25
3,554
76,960
0.02%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
reduced
-17.8
-4,184
22,419
0.01%
2023-09-07
ST GERMAIN D J CO INC
new
-
1,183,260
1,183,260
0.06%
2023-09-07
JAG CAPITAL MANAGEMENT, LLC
added
1.59
95,903
2,412,940
0.28%
2023-09-05
SILVIA MCCOLL WEALTH MANAGEMENT, LLC
unchanged
-
5,175
210,936
0.20%
2023-08-29
Garde Capital, Inc.
new
-
100,000
100,000
0.01%
2023-08-28
DT Investment Partners, LLC
unchanged
-
-5,508
104,231
0.01%
2023-08-25
Gould Capital, LLC
unchanged
-
485
19,799
0.01%
2023-08-25
Brown Shipley& Co Ltd
added
39.64
114,939
381,271
0.16%

1–10 of 48

Latest Funds Activity

Are funds buying CL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CL
No. of Funds

Schedule 13G FIlings of Colgate-Palmolive

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
9.62%
80,375,011
SC 13G/A
Feb 06, 2023
state street corp
5.97%
49,899,351
SC 13G/A
Feb 03, 2023
blackrock inc.
8.1%
68,041,416
SC 13G/A
Feb 14, 2022
state street corp
5.89%
49,608,335
SC 13G/A
Feb 09, 2022
vanguard group inc
9.11%
76,746,614
SC 13G/A
Feb 01, 2022
blackrock inc.
7.7%
65,218,485
SC 13G/A
Feb 12, 2021
state street corp
5.92%
50,722,444
SC 13G
Feb 10, 2021
vanguard group inc
8.83%
75,657,186
SC 13G/A
Jan 29, 2021
blackrock inc.
6.8%
58,107,209
SC 13G/A
Feb 14, 2020
state street corp
6.57%
56,280,269
SC 13G

Recent SEC filings of Colgate-Palmolive

View All Filings
Date Filed Form Type Document
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
4
Insider Trading
Sep 15, 2023
8-K
Current Report
Sep 13, 2023
4
Insider Trading

Peers (Alternatives to Colgate-Palmolive)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.9B
82.0B
0.69% 12.10%
25.07
4.46
2.27% -0.60%
63.2B
18.7B
-1.78% -3.04%
35.42
3.52
5.51% -22.99%
48.5B
20.4B
-3.02% 1.26%
24.55
2.39
1.47% -8.06%
23.2B
-
1.88% 24.27%
52
75.72
-94.06% -42.72%
17.1B
7.4B
-10.02% -2.31%
115.04
2.32
3.97% -67.75%
MID-CAP
6.1B
672.6M
-4.71% 184.69%
61.19
9.1
61.02% 257.75%
5.4B
3.9B
-6.17% -5.71%
22.91
1.4
4.88% -13.50%
3.2B
2.9B
-0.11% 68.55%
1.78
1.1
-6.79% 1581.68%
2.8B
527.2M
-3.34% 10.22%
43.84
5.34
4.68% 5.34%
2.5B
3.3B
7.06% 24.13%
20.49
0.76
-3.05% -20.06%
2.4B
2.9B
-0.47% 22.37%
-10.09
0.83
-2.87% -212.81%
SMALL-CAP
305.4M
432.4M
0.76% 83.37%
45.86
0.71
-3.33% -61.91%
35.2M
10.4M
1.59% -37.75%
15.72
3.39
-27.57% -39.04%

Colgate-Palmolive News

MarketBeat
Colgate-Palmolive (NYSE:CL) Shares Sold by Patton Albertson ....
MarketBeat,
6 hours ago
GuruFocus.com

Returns for CL

Cumulative Returns on CL

4.1%


10-Year Cumulative Returns

2.3%


7-Year Cumulative Returns

3.3%


5-Year Cumulative Returns

0.6%


3-Year Cumulative Returns

Risks for CL

What is the probability of a big loss on CL?

4.6%


Probability that Colgate-Palmolive stock will be more than 20% underwater in next one year

0%


Probability that Colgate-Palmolive stock will be more than 30% underwater in next one year.

0%


Probability that Colgate-Palmolive stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Colgate-Palmolive was unfortunately bought at previous high price.

Drawdowns

Financials for Colgate-Palmolive

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.8%18,67618,33817,96717,74117,70017,47617,42117,34217,08116,71816,47116,16215,93715,90615,69315,48915,40615,42615,54415,62515,754
Cost Of Revenue1.3%8,0557,9507,7197,5087,3927,1667,0466,8836,7056,5296,4546,3746,3736,4036,3686,3256,2896,3166,3136,3196,334
Gross Profit2.2%10,62110,38810,24810,23310,30810,31010,37510,45910,37610,18910,0179,7889,5649,5039,3259,1649,1179,1109,2319,3069,420
  S&GA Expenses1.7%6,7936,6826,5656,5306,5326,4436,4076,4426,3246,1516,0195,7985,7095,6835,5755,4915,4315,3625,3895,4065,447
  R&D Expenses---320---307---290---281---277--
EBITDA-100.0%-3,1333,377-3,3713,6763,837--4,4404,3744,3414,1644,0914,0053,9703,9934,0594,1704,1904,271
EBITDA Margin-100.0%-0.17*0.19*-0.19*0.21*0.22*--0.27*0.27*0.27*0.26*0.26*0.26*0.26*0.26*0.26*0.27*0.27*0.27*
Interest Expenses-258-172-130-120---184---193---195--
Earnings Before Taxes1.9%2,4722,4262,6602,8522,8132,9253,0873,6573,7713,7093,6473,6233,4503,3823,3013,2633,2893,3543,4643,5283,608
EBT Margin-100.0%-0.13*0.15*0.16*0.16*0.17*0.18*0.21*0.22*0.22*0.22*0.22*0.22*0.21*0.21*0.21*0.21*0.22*0.22*0.23*0.23*
Net Income-6.3%1,4971,5981,7851,9281,9442,0442,1662,6652,7292,6612,6952,6912,5712,5222,3672,3302,2752,3262,4002,1172,201
Net Income Margin-100.0%-0.09*0.10*0.11*0.11*0.12*0.12*0.15*0.16*0.16*0.16*0.17*0.16*0.16*0.15*0.15*0.15*0.15*0.15*0.14*0.14*
Free Cashflow-100.0%-2,9052,5562,9893,0142,5462,758--3,1403,3103,3913,3432,9612,7982,5892,5722,6092,6202,4002,493
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets0.3%16,22716,17315,73116,28815,71115,72315,04015,88015,99915,80115,92015,46615,14115,07015,03415,02613,15112,88312,16112,57112,650
  Current Assets-0.5%5,4375,4665,1135,2785,1604,9894,3974,6704,6524,5634,3384,3674,2124,2484,1794,3494,2554,1333,7934,1414,172
    Cash Equivalents-5.5%819867775938858877832958937995888989997854883948863843726841833
  Inventory-3.4%2,0392,1102,0742,0732,0121,9241,6921,6701,7001,6761,6731,5781,5241,3011,4001,3711,3221,2781,2501,2451,254
  Net PPE1.6%4,4314,3634,3074,1233,7653,7523,7303,6333,6653,6093,7163,5063,4833,4873,7503,6893,7933,8213,8813,8713,908
  Goodwill-0.1%3,3733,3753,3524183,2383,2923,2843,6853,7533,7013,8243,7113,6283,5593,5089232,5362,5172,5302,5392,483
Liabilities1.0%15,91215,74814,92515,23515,15314,99514,06914,85315,13715,13814,81914,39314,40914,72914,47614,85213,16113,09311,96412,63912,839
  Current Liabilities4.3%4,6324,4414,0044,4924,3954,5664,0514,2814,2034,5394,4044,4814,5804,4434,0384,2313,7823,8653,3413,7473,942
    LT Debt, Current6.7%16.0015.0014.0013.0013.0012.0012.0011.0010.009.009.002562552552542.001.001.00---
    LT Debt, Non Current0.9%8,9548,8708,7418,2197,9577,5887,1947,6827,9517,5707,3346,9716,8847,3367,3337,6466,6406,6556,3546,5196,519
Shareholder's Equity-Infinity%-64.00-401622168321609591464262743653268-117------
  Retained Earnings0.4%24,25824,15324,57324,56624,34224,14924,35024,20123,94623,62423,69923,05222,73122,48122,50121,86021,65321,43621,61521,00820,851
  Additional Paid-In Capital2.4%3,6883,6033,5463,5183,4023,3553,2693,1743,0853,0112,9692,8372,6662,6232,4882,4662,3382,2412,2042,1832,081
Accumulated Depreciation1.9%5,5575,4525,2765,1955,2495,2915,1695,1945,1835,0285,0354,8744,7144,6804,8304,7004,6834,5774,4554,5804,500
Minority Interest-12.1%379431405431390407362436398401358420464454441498337342299362334
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations6.7%3,0992,9052,5562,9893,0143,1133,3253,1823,1503,5493,7193,7263,6783,2963,1333,0253,0083,0453,0562,9533,046
  Share Based Compensation6.4%11711012513312212613512913312910710298.0099.0010095.0096.0098.00109118121
Cashflow From Investing9.7%-1,557-1,724-1,601-1,558-785-591-592-573-551-462-779-692-2,404-2,460-2,099-2,071-369-387-1,170-1,113-1,172
Cashflow From Financing-35.5%-1,522-1,123-952-1,392-2,275-2,644-2,774-2,619-2,662-2,945-2,919-2,988-1,107-786-870-828-2,604-2,634-2,679-2,384-2,310
  Buy Backs-0.9%1,0681,0781,3081,2511,3981,3581,3201,8621,9611,6281,4767567661,0231,2021,3061,2061,2861,2381,3001,435

CL Income Statement

2023-06-30
Condensed Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales$ 4,822$ 4,484$ 9,592$ 8,883
Cost of sales2,0351,9304,0933,757
Gross profit2,7872,5545,4995,126
Selling, general and administrative expenses1,7681,6573,5263,298
Other (income) expense, net45139084
Operating profit9748841,8831,744
Non-service related postretirement costs291232350
Interest (income) expense, net583111258
Income before income taxes8878411,4481,636
Provision for income taxes353202500394
Net income including noncontrolling interests5346399481,242
Less: Net income attributable to noncontrolling interests32367480
Net income attributable to Colgate-Palmolive Company$ 502$ 603$ 874$ 1,162
Earnings per common share, basic (in dollars per share)$ 0.61$ 0.72$ 1.05$ 1.39
Earnings per common share, diluted (in dollars per share)$ 0.60$ 0.72$ 1.05$ 1.38

CL Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets  
Cash and cash equivalents$ 819$ 775
Receivables (net of allowances of $82 and $70, respectively)1,6561,504
Inventories2,0392,074
Other current assets923760
Total current assets5,4375,113
Property, plant and equipment:  
Cost9,9889,583
Less: Accumulated depreciation(5,557)(5,276)
Property, plant and equipment, net4,4314,307
Goodwill3,3733,352
Other intangible assets, net1,9011,920
Deferred income taxes186135
Other assets899904
Total assets16,22715,731
Current Liabilities  
Notes and loans payable1911
Current portion of long-term debt1614
Accounts payable1,5441,551
Accrued income taxes453317
Other accruals2,6002,111
Total current liabilities4,6324,004
Long-term debt8,9548,741
Deferred income taxes363383
Other liabilities1,9631,797
Total liabilities15,91214,925
Shareholders’ Equity  
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)1,4661,466
Additional paid-in capital3,6883,546
Retained earnings24,25824,573
Accumulated other comprehensive income (loss)(3,935)(4,055)
Unearned compensation0(1)
Treasury stock, at cost(25,541)(25,128)
Total Colgate-Palmolive Company shareholders’ equity(64)401
Noncontrolling interests379405
Total equity315806
Total liabilities and equity$ 16,227$ 15,731
Noel R. Wallace
33800
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.